Skip to main content
Clinical Trials/JPRN-UMIN000018114
JPRN-UMIN000018114
Completed
未知

Diagnosis of pancreatobiliary cancer by measuring the urinary and serum levels of porphyrins after oral administration of 5-aminolevulinic acid. - Diagnosis of pancreatobiliary cancer by measuring the urinary and serum levels of porphyrins.

Kansai Medical University0 sites67 target enrollmentJuly 1, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Patients who have suspected pancreatobiliary disease.
Sponsor
Kansai Medical University
Enrollment
67
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 1, 2015
End Date
December 31, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Patients with porphyria. 2\.Patients with hypersensitivity to 5\-aminolevulinic acid or porphyrins. 3\.In cases of known or suspected pregnancy or woman who are breast\-feeding. 4\.Patients who doctors regard as inappropriate ones for the enrollment due to some reasons.

Outcomes

Primary Outcomes

Not specified

Similar Trials